Annual Report and Accounts

RNS Number : 7193U

Immupharma PLC

30 June 2009

 



For Immediate Release

30 June 2009

ImmuPharma PLC

Annual Report and Accounts

In accordance with Rule 20 of the AIM Rules, ImmuPharma PLC (AIM:IMM), the specialist drug discovery and development company, confirms that the Annual Report and Accounts for the year ended 31 December 2008, has been posted to shareholders. 

The annual report is available, in electronic form, for download on the Company's website www.immupharma.com. 

The Company's Annual General Meeting will be held on 24 July 2009 at 11am at 50 Broadway, London, SW1H 0BL.

Ends

For further information please contact: 

ImmuPharma PLC:
Dimitri Dimitriou, Chief Executive Officer	[phone]
Richard Warr, Chairman	[phone]
Buchanan Communications	+ 44 20 7466 5000
Lisa Baderoon
Rebecca Skye Dietrich
Panmure Gordon & Co
Andrew Burnett	[phone]

 

END

 

 

ACSFLMFTMMMTBPL